Organization | Government of Denmark

Government of Denmark Report issue

Government Phase 1 Phase 2 Phase 3 Phase 4

Founded: Copenhagen Denmark (1848)

Organization Overview

First Clinical Trial

1998

NCT00206960

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Now

Alternative names

Capital Region, Copenhagen, Denmark | Capital Region Pharmacy, Denmark | Center of Clinical Research, Regional Hospital North Jutland, Hjørring, Denmark | Copenhagen Municipality, Denmark | Danish Center of Particle Therapy | Danish Committee for Health Education | Danish Comprehensive Cancer Center | Danish Lymphoma Group | Danish Study Group | Danish Veterans Centre | Emergency Medical Services, Capital Region, Denmark | Fund for Research, Quality and Education in Physiotherapy Practice | Independent Research Fund Denmark | Kolding Municipality, Denmark | Mental Health Services Capital Region Denmark | Mental Health Services in the Capital Region of Denmark | Military Psychology Department, Danish Veteran Centre | Ministery of Economic affairs | Ministry of the Interior and Health, Denmark | Municipalities of Northern Jutland, Denmark | Municipality of Herlev | Municipality of Koege, Denmark | Municipality of Odense | National Allergy Research Center | National Allergy Research Center, Denmark | National Board of Health, Denmark | North Denmark Region | Northern Orthopaedic Division, Denmark | Region Capital Denmark | Sten Rasmussen, MD, PhD | The Danish Committee of Health Education | The Danish Medical Research Council | The Ministry of Science, Technology and Innovation, Denmark | The Municipality of Odense, Denmark

Active Ingredients

Drugs in Phase 4 Trials (14)

aripiprazole (abilify) (1 trial)

azd1222 (1 trial)

bnt162b2 (1 trial)

chlorzoxazone (parafon forte dsc) (1 trial)

enalapril (vasotec) (1 trial)

escitalopram (lexapro) (1 trial)

esomeprazole (nexium) (1 trial)

methylphenidate (ritalin) (2 trials)

mirtazapine (remeron) (1 trial)

mrna-1273 (1 trial)

oxygen (2 trials)

polidocanol (asclera) (1 trial)

quetiapine (seroquel) (2 trials)

ropivacaine (naropin) (2 trials)

Drugs in Phase 3 Trials (6)

albumin (Human) (Plasbumin) (1 trial)

bacille calmette-guerin (1 trial)

clarithromycin (biaxin) (1 trial)

iloprost (ventavis) (1 trial)

immune globulin (human) (1 trial)

letrozole (femara) (3 trials)

Drugs in Phase 2 Trials (9)

alecsat (1 trial)

autologous blood (1 trial)

calcium (1 trial)

cisplatin (platinol) (1 trial)

epoetin (Epogen) (1 trial)

gemcitabine (gemzar) (1 trial)

progesterone (progestasert) (1 trial)

teriparatide (1 trial)

tislelizumab (1 trial)

Drugs in Phase 1 Trials (12)

afo-18 (2 trials)

autologous bone graft (1 trial)

bone morphogenetic protein-2 (1 trial)

ferrofumerat (1 trial)

glucosamine (1 trial)

ibudilast (1 trial)

ibuprofen (motrin) (2 trials)

lidocaine (xylocaine) (2 trials)

mecasermin (increlex) (1 trial)

sodium chloride (1 trial)

vitamin d3 (1 trial)

Drugs in Other Trials (29)

acetaminophen (tylenol) (3 trials)

amiloride (midamor) (1 trial)

cortisone acetate (cortone) (1 trial)

elemental gold (2 trials)

epinephrine (levophed) (1 trial)

glp-2 (1 trial)

glucagon-like peptide-1 (2 trials)

high-selenium yeast (1 trial)

hydrolyzed casein (2 trials)

imipramine (tofranil) (1 trial)

ketorolac (acuvail) (1 trial)

lactobacillus plantarum (1 trial)

levobupivacaine (chirocaine) (1 trial)

maltodextrin (2 trials)

methylprednisolone (medrol) (1 trial)

milk protein (1 trial)

morphine (1 trial)

nickel sulfate hexahydrate (1 trial)

nicotine (nicorette) (1 trial)

pantoprazole (protonix) (2 trials)

probiotic (1 trial)

red clover extract (1 trial)

resveratrol (5 trials)

risperidone (risperdal) (1 trial)

sodium aluminium phospate (1 trial)

somatostatin (1 trial)

whey protein (1 trial)

zuclopenthixol hydrochloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Abortion, Habitual (Phase 3)

Abortion, Spontaneous (Phase 3)

Acquired Immunodeficiency Syndrome (Phase 1)

Acute Coronary Syndrome (Phase 4)

Bipolar Disorder (Phase 2)

Bone Diseases (Phase 1)

Breast Neoplasms (Phase 3)

Cardiovascular Diseases (Phase 3)

Coronary Artery Disease (Phase 3)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Disease (Phase 4)

Dyspepsia (Phase 4)

Fractures, Bone (Phase 2)

Headache (Phase 1)

Heart Diseases (Phase 3)

Hip Fractures (Phase 2)

HIV Infections (Phase 1)

Infections (Phase 1)

Infertility (Phase 3)

Mental Disorders (Phase 4)

Migraine Disorders (Phase 1)

Mood Disorders (Phase 4)

Myocardial Ischemia (Phase 3)

Neoplasm Metastasis (Phase 3)

Osteoarthritis (Phase 4)

Osteoarthritis, Hip (Phase 4)

Osteoarthritis, Knee (Phase 4)

Pain, Postoperative (Phase 1)

Premature Birth (Phase 2)

Psychotic Disorders (Phase 4)

Shock (Phase 3)

Shock, Septic (Phase 3)

Shoulder Fractures (Phase 2)

Tendinopathy (Phase 4)

Tibial Fractures (Phase 1)

Triple Negative Breast Neoplasms (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 65
# of Trial APIs: 70